Evofem Reports Fifth Consecutive Year of Net Sales Growth
Women’s health innovator Evofem Biosciences, Inc. (Evofem or the Company) (OTCID: EVFM), today announced financial results for the fourth quarter and year ended December 31, 2025. Highlights include:
Evofem Expands “Say Vagina” Campaign With Launch of Say Vagina Store
Evofem Biosciences, Inc. (“Evofem” or the “Company”) (OTCID: EVFM) today announced the launch of the Say Vagina Store, expanding its groundbreaking Say Vagina campaign aimed at normalizing accurate anatomical language and advancing education and autonomy in women’s health.
